计算溶液所需的质量、体积或浓度。
ADRA1D receptor antagonist 1 is a potent, selective and orally active α 1D adrenoceptor antagonist, with a K i of 1.6 nM
In Vitro
ADRA1D receptor antagonist 1 shows low hERG inhibition. ADRA1D receptor antagonist 1 exhibits higher selectivity for α1D-AR over α1A- and α1B-ARs. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
ADRA1D receptor antagonist 1 (4.4 µg/kg; i.v.) dose-dependently decreases the non-voiding bladder contractions during the urinary storage phase in rats with BOO . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Rat with bladder outlet obstruction (BOO) Dosage: 4.4 µg/kg Administration: Intravenous injection Result: Dose-dependently decreased the non-voiding bladder contractions during urinary storage phase in rats with BOO.
IC50& Target:Ki: 1.6 nM (α 1D adrenoceptor)